When the erythroblasts from cord blood and MDS patients were treated with pGSN, GATA-1 mRNA expression, which increases during erythroblasts maturation and positively regulates erythropoiesis [25], was up-regulated compared to that in untreated controls (Figure 5B,C). Here, GATA1 is linked to myelodysplastic syndrome.